| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0082 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1161174dbf6d8e0cb34d794b6c50e9bb |
| publicationDate |
2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005159390-A1 |
| titleOfInvention |
Treatment and prevention of HIV and other viral infections |
| abstract |
Methods for preventing or treating a viral infection in a subject are described that include administering N-glycolylneuraminic acid or a derivative thereof to the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535732-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010119558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017100419-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006193907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7901715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221526-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8628793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522158-B2 |
| priorityDate |
1998-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |